Literature DB >> 19001851

Cdk5 and the non-catalytic arrest of the neuronal cell cycle.

Jie Zhang1, Karl Herrup.   

Abstract

Cyclin-dependent kinase 5 (Cdk5) is a nontraditional Cdk that is primarily active in postmitotic neurons. An important core function of Cdk5 involves regulating the migration and maturation of embryonic post-mitotic neurons. These developmental roles are dependent on its kinase activity. Initially, there was little evidence indicating a role for Cdk5 in normal cell cycle regulation. Recent data from our lab, however, suggest that Cdk5 plays a crucial role as a cell cycle suppressor in normal post-mitotic neurons and neuronal cell lines. It performs this foundation in a kinase independent manner. Cdk5 normally found in both nucleus and cytoplasm, but it exits the nucleus in neurons risk to death in an AD patient's brain. The shift in sub-cellular location is accompanied by cell cycle re-entry and neuronal death. This "new" function of Cdk5 raises cautions in the design of Cdk5-directed drugs for the therapy of neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19001851      PMCID: PMC3743047          DOI: 10.4161/cc.7.22.7045

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  70 in total

1.  Gene expression changes in response to E2F1 activation.

Authors:  Jens Stanelle; Thorsten Stiewe; Carmen C Theseling; Martin Peter; Brigitte M Pützer
Journal:  Nucleic Acids Res       Date:  2002-04-15       Impact factor: 16.971

Review 2.  Sibling rivalry in the E2F family.

Authors:  Jeffrey M Trimarchi; Jacqueline A Lees
Journal:  Nat Rev Mol Cell Biol       Date:  2002-01       Impact factor: 94.444

3.  Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease.

Authors:  T Arendt; M Holzer; U Gärtner
Journal:  J Neural Transm (Vienna)       Date:  1998       Impact factor: 3.575

4.  p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis.

Authors:  G Rodier; A Montagnoli; L Di Marcotullio; P Coulombe; G F Draetta; M Pagano; S Meloche
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

5.  Cyclin D2 interacts with cdk-5 and modulates cellular cdk-5/p35 activity.

Authors:  S Guidato; D M McLoughlin; A J Grierson; C C Miller
Journal:  J Neurochem       Date:  1998-01       Impact factor: 5.372

6.  Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain.

Authors:  J Busser; D S Geldmacher; K Herrup
Journal:  J Neurosci       Date:  1998-04-15       Impact factor: 6.167

7.  Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth.

Authors:  G Paglini; G Pigino; P Kunda; G Morfini; R Maccioni; S Quiroga; A Ferreira; A Cáceres
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

8.  The cyclin-dependent kinase 5 activators p35 and p39 interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner.

Authors:  Rani Dhavan; Paul L Greer; Maria A Morabito; Lianna R Orlando; Li-Huei Tsai
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

9.  Expression of cyclin-dependent kinase 5 and associated cyclins in Leydig and Sertoli cells of the testis.

Authors:  F R Musa; M Tokuda; Y Kuwata; T Ogawa; K Tomizawa; R Konishi; I Takenaka; O Hatase
Journal:  J Androl       Date:  1998 Nov-Dec

10.  Cyclin-dependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex.

Authors:  E C Gilmore; T Ohshima; A M Goffinet; A B Kulkarni; K Herrup
Journal:  J Neurosci       Date:  1998-08-15       Impact factor: 6.167

View more
  23 in total

1.  MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons.

Authors:  Sabrina Absalon; Dawn M Kochanek; Venkatesan Raghavan; Anna M Krichevsky
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

2.  Cell cycle activation and CNS injury.

Authors:  Bogdan A Stoica; Kimberly R Byrnes; Alan I Faden
Journal:  Neurotox Res       Date:  2009-04-21       Impact factor: 3.911

3.  CDK5 phosphorylates DRP1 and drives mitochondrial defects in NMDA-induced neuronal death.

Authors:  Arezu Jahani-Asl; En Huang; Isabella Irrcher; Juliet Rashidian; Naotada Ishihara; Diane C Lagace; Ruth S Slack; David S Park
Journal:  Hum Mol Genet       Date:  2015-05-22       Impact factor: 6.150

Review 4.  Cell cycle activation and spinal cord injury.

Authors:  Junfang Wu; Bogdan A Stoica; Alan I Faden
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

5.  Iron Oxide Nanoparticles Induces Cell Cycle-Dependent Neuronal Apoptosis in Mice.

Authors:  Vijayprakash Manickam; Vasanth Dhakshinamoorthy; Ekambaram Perumal
Journal:  J Mol Neurosci       Date:  2018-01-24       Impact factor: 3.444

6.  CYY-1/cyclin Y and CDK-5 differentially regulate synapse elimination and formation for rewiring neural circuits.

Authors:  Mikyoung Park; Shigeki Watanabe; Vivian Yi Nuo Poon; Chan-Yen Ou; Erik M Jorgensen; Kang Shen
Journal:  Neuron       Date:  2011-05-26       Impact factor: 17.173

7.  Cyclin-dependent kinase 5 regulates E2F transcription factor through phosphorylation of Rb protein in neurons.

Authors:  Akira Futatsugi; Elias Utreras; Parvathi Rudrabhatla; Howard Jaffe; Harish C Pant; Ashok B Kulkarni
Journal:  Cell Cycle       Date:  2012-04-15       Impact factor: 4.534

Review 8.  Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders.

Authors:  Jerel Adam Fields; Wilmar Dumaop; Leslie Crews; Anthony Adame; Brian Spencer; Jeff Metcalf; Johnny He; Edward Rockenstein; Eliezer Masliah
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

9.  Conditional deletion of neuronal cyclin-dependent kinase 5 in developing forebrain results in microglial activation and neurodegeneration.

Authors:  Satoru Takahashi; Toshio Ohshima; Motoyuki Hirasawa; Tej K Pareek; Thomas H Bugge; Alexei Morozov; Kenji Fujieda; Roscoe O Brady; Ashok B Kulkarni
Journal:  Am J Pathol       Date:  2009-11-30       Impact factor: 4.307

Review 10.  A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease Pathogenesis.

Authors:  Craig S Atwood; Richard L Bowen
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.